Please login to the form below

Not currently logged in
PMLiVE Top Pharma List


The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Diovan/Co-Diovan was produced by Novartis.

Daiichi Sankyo strengthens US presence with Azor approval

Azor will now compete with Novartis' Exforge, a combination of amlodipine and Diovan, which was approved by the FDA in June 2007.

People, June, 2005

Zoe Healey joins from Grayling, where she worked on PR for pharma, biotech and service companies, and will work with the global Diovan team among others.

New Accounts: March

Novartis. Aclasta. CRM. MRM Worldwide. Novartis. Diovan/Codiovan. Hypertension. TVF Communications. Novartis. ... Zaicom MMC. Pfizer. Diovan/Codiovan. Hypertension. TVF Communications. Pfizer. Vfend. Haematology. Zaicom MMC.

New Accounts: April

NICE. At Ri-SK? awareness campaign. Solar keratosis. hsdcommunications. Novartis. Diovan/Codiovan. Hypertension.

New accounts: February

Pfizer. Diovan/Codiovan. Hypertension. TVF Communications. Pfizer. Injectable contraceptive. Contraception. Ruder Finn.

[ Previous 5 results ] 6 7 8 9 10 11 12 13 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs


Add my company
Nobull Communications

Switched on Creative Communications. With an encyclopedic working knowledge of pharmaceutical industry rules and regulations, we create dynamic, intuitive and...

Latest intelligence

What challenges still face clinical trial recruitment and retention?
Discover the reasons for the current clinical trial recruitment challenges facing pharma and the life sciences industry, and how the search for solutions to the problem continues...
“Fake News” and Credibility in Medical Publishing
Natalie Yeadon from Impetus Digital shares her thoughts on fighting fake news in Pharma and healthcare....
Delivering true value: what does it mean for KAM in cancer care?
Lisa Alderson, Business Development Director at Wilmington Healthcare, explores the challenges that pharma’s KAM teams face in engaging with the NHS and how they must evolve...